This Is Why Zymergen's IPO Was a Huge Success
Polymer manufacturing technology has come a long way since a random guest at Mrs. Robinson's pool party told Dustin Hoffman there's a great future in plastics. Mr. McGuire was right, but his head would have exploded if he knew what synthetic biology upstarts like Zymergen (NASDAQ: ZY) had in store.
Zymergen's unique application of machine learning and robotic automation techniques to biological systems has captured imaginations and lots of capital, even though the company doesn't have a steady source of revenue yet. Here's why investors keep shoveling money at this high-risk start-up.
Image source: Getty Images.
Source Fool.com
